Impel Pharmaceuticals Inc. (NASDAQ:IMPL) shareholders will doubtless be very grateful to see the share price up 70% in the last month. But that's small comfort given the dismal price performance over ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
The recent 16% drop in Impel Pharmaceuticals Inc.'s (NASDAQ:IMPL) stock could come as a blow to insiders who purchased US$108k worth of stock at an average buy price of US$10.76 over the past 12 ...
Every investor in Impel Pharmaceuticals Inc. (NASDAQ:IMPL) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results